CN1 COST-EFFECTIVENESS ANALYSIS OF OXALIPLATIN/5-FU/LV IN ADJUVANT TREATMENT OF STAGE III COLON CANCER IN THE UK AND GERMANY
Abstract
Authors
S Aballea J Chancellor M Raikou M Drummond R Diel M Frick S Rosenfeld A Boler S Jourdan C Paulo J Bridgewater